Orient EuroPharma Balance Sheet Health
Financial Health criteria checks 3/6
Orient EuroPharma has a total shareholder equity of NT$5.9B and total debt of NT$4.6B, which brings its debt-to-equity ratio to 76.7%. Its total assets and total liabilities are NT$12.5B and NT$6.6B respectively. Orient EuroPharma's EBIT is NT$155.9M making its interest coverage ratio 3.3. It has cash and short-term investments of NT$1.6B.
Key information
76.7%
Debt to equity ratio
NT$4.56b
Debt
| Interest coverage ratio | 3.3x |
| Cash | NT$1.58b |
| Equity | NT$5.95b |
| Total liabilities | NT$6.56b |
| Total assets | NT$12.51b |
Recent financial health updates
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden
Apr 04
We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt
Jan 04
Recent updates
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden
Apr 04Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?
Mar 04A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns
Feb 10Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?
Jan 22We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt
Jan 04A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)
Dec 17Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?
Nov 29Financial Position Analysis
Short Term Liabilities: 4120's short term assets (NT$4.0B) exceed its short term liabilities (NT$4.0B).
Long Term Liabilities: 4120's short term assets (NT$4.0B) exceed its long term liabilities (NT$2.6B).
Debt to Equity History and Analysis
Debt Level: 4120's net debt to equity ratio (50.3%) is considered high.
Reducing Debt: 4120's debt to equity ratio has increased from 37.1% to 76.7% over the past 5 years.
Debt Coverage: 4120's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4120's interest payments on its debt are well covered by EBIT (3.3x coverage).